Navigation Links
deCODE genetics Announces First Quarter 2009 Financial Results
Date:5/11/2009

week following the call. A digitized telephone replay of the call can be accessed for the week following the call by dialing 1 800 475 6701 from the US, or +1 320 365 3844 from outside the US. The access code is 100482.

               Condensed Consolidated Statements of Operations

                                                       For the three months
                                                           ended March 31,
                                                        2009          2008
                                                       In thousands, except
                                                         per share amounts
                                                            (unaudited)

    Revenue...................................... $    8,917    $   14,978
    OPERATING EXPENSES
    Cost of revenue............................        8,184        14,714
    Research and development...............            4,233        12,653
    Selling, general and administrative.......         4,903         7,211
    Total operating expense...........                17,320        34,578
    Operating loss................................    (8,403)      (19,600)
    Interest income..............................        157         1,037
    Interest expense.............................     (4,626)       (4,025)
    Other non-operating income and (expense), net*.      235        (4,077)
    Net loss ....................................  $ (12,637)    $ (26,665)
    Basic and diluted net loss per share:          $   (0.21)    $   (0.44)
    Shares used in computing basic and
    diluted net loss per share...................     61,489        61,266




               Condensed Consolidated Balance Sheet Data

                                            At March 31,   At December 31,
                                                 2009           2008
                                             
'/>"/>
SOURCE deCODE genetics Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2009 Financial Results
2. Nasdaq Stays Suspension of Trading in deCODE Stock
3. deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
4. deCODE to Utilize Grace Period for Interest Payment on Senior Convertible Notes
5. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2008 Financial Results
6. Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack
7. deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market
8. deCODE Discovers First Genetic Variant Conferring Increased Risk of Essential Tremor
9. deCODE Sells Auction Rate Securities
10. Introducing deCODEme Cardio(TM) and deCODEme Cancer(TM)
11. deCODE Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 Bina Technologies, Inc. (Bina, ... they have been acquired by Roche (SIX: RO, ROG; ... held company that provides a big data platform for ... data for the academic and translational research markets.  Bina ... will continue to focus on development of their innovative ...
(Date:12/19/2014)... Arlington, MA (PRWEB) December 18, 2014 ... products for ophthalmology and wound care. The National Eye ... has awarded LayerBio a Phase I SBIR grant to ... , Cataracts are the most common cause of vision ... cause of blindness worldwide. According to Dr. Ken Mandell, ...
(Date:12/19/2014)... The empty capsules market is experiencing growth primarily ... innovations in the empty capsules market. The fast-growing ... of the empty capsules market. , Get Full ... Report , The report will enrich both established ... gauge the pulse of the market which in ...
(Date:12/19/2014)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company ... announced the results of its annual general meeting of ... year in Relmada,s history and it set the stage ... Sergio Traversa , chief executive officer of Relmada. "Over ... human resource and clinical development objectives that position Relmada ...
Breaking Biology Technology:Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2
... TEL-AVIV, Israel, October 17 TopSpin Medical,(TASE: TOPMD), ... MRI,using an IntraVascular MRI (IVMRI) catheter for the ... Ph.D., as Vice President,Clinical Affairs. Dr. Setum ... research in,the medical device industry. She has a ...
... Oct. 17 Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ... that its lead product candidate, picoplatin,has been granted ... cell lung cancer (SCLC) by the European Commission. ... Committee for Orphan Medicinal,Products (COMP) of the European ...
... GenVault announced today that,the Henry C. Witelson Ocular ... purchased a Personal Archive biosample management system.,The laboratory ... will be a critical component of the Laboratory,s,research ... as uveal,melanoma and retinoblastoma and for developing new ...
Cached Biology Technology:TopSpin Medical Appoints Cindy Setum, Ph.D., Vice President Clinical Affairs 2Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 2Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 3Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 4McGill University Purchases GenVault's Personal Archive System to Manage Rare Cancer Samples 2
(Date:12/10/2014)... 2014 You,ve been here before: you desperately need ... your password, site key or the answer to your secret ... teacher? Today, Hoyos Labs , a ... will finally put an end to the frustration that comes ... . 1U leverages a user,s smartphone to acquire his or ...
(Date:12/10/2014)...     Jifflenow ...   Jifflenow, a leading provider ... business-to-business (B2B) events, today announced a partnership with ... communication (NFC), Bluetooth low energy (BLE), and cloud-based ... Jifflenow will integrate its meeting scheduling ...
(Date:12/3/2014)... , Dec. 2, 2014 As part of ... Inception Technologies is pleased to announce the release of ... customers to collect the workforce data that they need. ... have been left by existing readers. Many such devices ... connectivity and modern technology. Older models force users to ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2
... Health announced today that it will fund 22 grants ... modifications to genes that result from diet, aging, stress, ... human diseases and biological processes. The awards ... of the NIH Roadmap for Medical Research,s Epigenomics Program. ...
... Prevention Institute at Kansas State University is being honored ... Prevention Roundtable. The K-State institute,s intern program has ... award, also called the MVP2 award, as the best ... Sept. 22, in Washington, D.C. The award is ...
... Calif., September 15, 2009 -- Researchers at the ... that reactive oxygen species, such as superoxide and ... invadopodia, cellular protrusions implicated in cancer cell migration ... director of the Tumor Microenvironment Program at Burnham,s ...
Cached Biology News:NIH funds grantees focusing on epigenomics of human health and disease 2NIH funds grantees focusing on epigenomics of human health and disease 3NIH funds grantees focusing on epigenomics of human health and disease 4K-State Pollution Prevention Institute's intern program named best 2Reactive oxygen's role in metastasis 2
Tissue-Stat ( Tissue Adherent for Mounting Formalin-Fixed and Frozen Tissue Sections.)...
This monoclonal antibody specifically recognizes Y. pestiscapsular F1 antigen. It does not cross-react with Y. pseudotuberculosisor Y. enterocolitica....
Clarin Mounting Medium (Permanent environmentally safe mounting medium for general histology & cytology use)...
... Plus is formulated for covering tissue sections and ... soluble OR alcohol insoluble end products. ... as Fast Red or AEC that require an ... such as DAB. No heating is required prior ...
Biology Products: